Productive Recognition of Factor IX by Factor XIa Exosites Requires Disulfide Linkage between Heavy and Light Chains of Factor XIa

被引:5
|
作者
Marcinkiewicz, Mariola M. [1 ]
Sinha, Dipali [1 ]
Walsh, Peter N. [1 ,2 ,3 ]
机构
[1] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA
[3] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA
基金
美国国家卫生研究院;
关键词
BLOOD-COAGULATION FACTOR; PLASMA THROMBOPLASTIN ANTECEDENT; CATALYTIC DOMAIN; CHRISTMAS-FACTOR; TISSUE FACTOR; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; BINDING-SITE; FACTOR XA; ACTIVATION;
D O I
10.1074/jbc.M111.291989
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the intrinsic pathway of blood coagulation factor XIa (FXIa) activates factor IX (FIX) by cleaving the zymogen at Arg(145)-Ala(146) and Arg(180)-Val(181) bonds releasing an 11-kDa activation peptide. FXIa and its isolated light chain (FXIa-LC) cleave S-2366 at comparable rates, but FXIa-LC is a very poor activator of FIX, possibly because FIX undergoes allosteric modification on binding to an exosite on the heavy chain of FXIa (FXIa-HC) required for optimal cleavage rates of the two scissile bonds of FIX. However preincubation of FIX with a saturating concentration of isolated FXIa-HC did not result in any potentiation in the rate of FIX cleavage by FXIa-LC. Furthermore, if FIX binding via the heavy chain exosite of FXIa determines the affinity of the enzyme-substrate interaction, then the isolated FXIa-HC should inhibit the rate of FIX activation by depleting the substrate. However, whereas FXIa/S557A inhibited FIX activation of by FXIa, FXIa-HC did not. Therefore, we examined FIX binding to FXIa/S557A, FXIa-HC, FXIa-LC, FXIa/C362S/C482S, and FXIa/S557A/C362S/C482S. The heavy and light chains are disulfide-linked in FXIa/S557A but not in FXIa/C362S/C482S and FXIa/S557A/C362S/C482S. In an ELISA assay only FXI/S557A ligated FIX with high affinity. Partial reduction of FXIa/S557A to produce heavy and light chains resulted in decreased FIX binding, and this function was regained upon reformation of the disulfide linkage between the heavy and the light chains. We therefore conclude that substrate recognition by the FXIa exosite(s) requires disulfide-linked heavy and light chains.
引用
收藏
页码:6187 / 6195
页数:9
相关论文
共 50 条
  • [41] HETEROGENEITY OF FACTOR-IX BM DIFFERENCE OF CLEAVAGE SITES BY FACTOR-XIA AND CA-2+ IN FACTOR-IX KASHIHARA, FACTOR-IX NAGOYA AND FACTOR-IX NIIGATA
    YOSHIOKA, A
    OHKUBO, Y
    NISHIMURA, T
    TANAKA, I
    FUKUI, H
    OGATA, K
    KAMIYA, T
    TAKAHASHI, H
    THROMBOSIS RESEARCH, 1986, 42 (05) : 595 - 604
  • [42] THE EFFECT OF PLATELETS IN THE ACTIVATION OF HUMAN-BLOOD COAGULATION FACTOR-IX BY FACTOR-XIA
    SOONS, H
    JANSSENCLAESSEN, T
    HEMKER, HC
    TANS, G
    BLOOD, 1986, 68 (01) : 140 - 148
  • [43] THE EFFECT OF ACTIVATED HUMAN-PLATELETS ON THE ACTIVATION OF HUMAN FACTOR-IX BY FACTOR-XIA
    SOONS, H
    JANSSENCLAESSEN, T
    TANS, G
    HEMKER, MC
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 149 - 149
  • [44] THE FACTOR-IX PHOSPHOLIPID-BINDING SITE IS REQUIRED FOR CALCIUM-DEPENDENT ACTIVATION OF FACTOR-IX BY FACTOR-XIA
    LIEBMAN, HA
    FURIE, BC
    FURIE, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (16) : 7605 - 7612
  • [45] Coagulation factor XIa enhances the binding of both zymogen and activated factor IX to stimulated human platelets.
    Oliver, JA
    Monroe, DM
    Gaud, K
    Roberts, HR
    Hoffman, M
    BLOOD, 1995, 86 (10) : 1786 - 1786
  • [46] IDENTIFICATION AND CHEMICAL SYNTHESIS OF A SUBSTRATE-BINDING SITE FOR FACTOR-IX ON COAGULATION FACTOR-XIA
    BAGLIA, FA
    JAMESON, BA
    WALSH, PN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (35) : 24190 - 24197
  • [47] Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa
    Van de Berg, Tom W.
    Beckers, Erik A. M.
    Heubel-Moenen, Floor C. J. I.
    Henskens, Yvonne M. C.
    Thomassen, M. Christella L. G. D.
    Hackeng, Tilman M.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (11) : 1034 - 1041
  • [48] Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa
    Buchanan, Malcolm S.
    Carroll, Anthony R.
    Wessling, Deborah
    Jobling, Michael
    Avery, Vicky M.
    Davis, Rohan A.
    Feng, Yunjiang
    Xue, Yafeng
    Oster, Linda
    Fex, Tomas
    Deinum, Johanna
    Hooper, John N. A.
    Quinn, Ronald J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (12) : 3583 - 3587
  • [49] Consequences for the APTT due to direct action of factor XIa on factor X, resulting in bypassing factors VIII-IX
    Kluft, C.
    van Leuven, C. J. M.
    THROMBOSIS RESEARCH, 2015, 135 (01) : 198 - 204
  • [50] THE ARG-4 MUTANT FACTOR-IX STRASBOURG-2 SHOWS A DELAYED ACTIVATION BY FACTOR XIA
    DELASALLE, C
    CHARMANTIER, JL
    RAVANAT, C
    OHLMANN, P
    HARTMANN, ML
    SCHUHLER, S
    BISCHOFF, R
    EBEL, C
    ROECKLIN, D
    BALLAND, A
    CAZENAVE, JP
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1993, 35 (05): : 473 - 480